MARKET

NSRX

NSRX

Nasus Pharma Ltd.
AMEX
6.80
-0.05
-0.73%
Opening 10:47 12/05 EST
OPEN
6.80
PREV CLOSE
6.85
HIGH
6.80
LOW
6.80
VOLUME
633
TURNOVER
--
52 WEEK HIGH
9.99
52 WEEK LOW
5.90
MARKET CAP
61.61M
P/E (TTM)
-22666.6667
1D
5D
1M
3M
1Y
5Y
1D
Nasus Pharma management to meet virtually with Citizens JMP
TipRanks · 1d ago
Weekly Report: what happened at NSRX last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at NSRX last week (1117-1121)?
Weekly Report · 11/24 09:23
Nasus Pharma Appoints Eyal Rubin as New CFO to Enhance Leadership
TipRanks · 11/20 13:55
Nasus Pharma Appoints Eyal Rubin As EVP And CFO
Benzinga · 11/20 13:16
Nasus Pharma Strengthens Leadership Team, Appointing Eyal Rubin as Executive Vice President and Chief Financial Officer
Barchart · 11/20 07:15
Nasus Pharma Initiates Phase 2 Study of Needle-Free Epinephrine
TipRanks · 11/18 13:47
Nasus Pharma Initiates Phase 2 Clinical Study To Evaluate NS002 Investigational Intranasal Epinephrine Powder Formulation With Dosing Of First Patient To Treat Anaphylaxis
Benzinga · 11/18 13:07
More
About NSRX
Nasus Pharma Ltd, located in Tel Aviv, Israel, is a manufacturer of pharmaceutical preparation.

Webull offers Nasus Pharma Ltd. stock information, including AMEX: NSRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NSRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NSRX stock methods without spending real money on the virtual paper trading platform.